SLC2A1 and neoplasm: Previous studies reported various associations between GLUT1 expression and tumor aggressiveness and a poor prognosis in a number of other malignancies including pancreatic, pulmonary, colorectal, hepatocellular, ovarian and squamous cell carcinoma [27, 28, 30-32].